Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,856 | 7,996 | 0 | 0 | 0 |
| Marketable Securities | 1,779 | 2,541 | 0 | 0 | 0 |
| TOTAL | $7,897 | $10,925 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 581 | 576 | N/A | N/A | N/A |
| Intangibles | 1,169 | 1,230 | 0 | 0 | 0 |
| TOTAL | $1,750 | $1,806 | $N/A | $N/A | $N/A |
| Total Assets | $9,647 | $12,731 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,873 | 1,132 | 0 | 0 | 0 |
| Accrued Expenses | 879 | 1,182 | 0 | 0 | 0 |
| TOTAL | $2,752 | $2,314 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,752 | $2,314 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,272 | N/A | N/A | N/A | N/A |
| Common Shares | 35,069 | 34,901 | 0 | 0 | 0 |
| Retained earnings | -27,062 | -24,134 | 0 | 0 | 0 |
| Other shareholders' equity | -1,112 | -350 | 0 | 0 | 0 |
| TOTAL | $6,895 | $10,417 | $0 | $0 | $0 |
| Total Liabilities And Equity | $9,647 | $12,731 | $0 | $0 | $0 |